Marina Delic-Sarac

Forsker
ved Institutt for kreftforskning ved Universitetet i Oslo

Resultater Resultater

A T cell receptor targeting a recurrent driver mutation in FLT3 mediates elimination of primary human acute myeloid leukemia in vivo.

Giannakopoulou, Eirini Chrysovalantou; Lehander, Madeleine; Virding Culleton, Stina; Yang, Weiwen; Li, Yingqian; Kärpänen, Terhi Hannele; Yoshizato, Tetsuichi; Rustad, Even Holth; Nielsen, Morten Milek; Bollineni, Ravi Chand mfl.. 2023, Nature Cancer. Uu, KAROLINSKA, DTU, UoO, NORD, UIO, OUS, LUMC, KI, AARHUSSYKEVitenskapelig artikkel

Prevalent and immunodominant CD8 T cell epitopes are conserved in SARS-CoV-2 variants.

Meyer, Saskia; Blaas, Isaac; Bollineni, Ravi Chand; Delic-Sarac, Marina; Tran, Trung; Knetter, Cathrine; Dai, Kezheng; Madssen, Torfinn Støve; Vaage, John T.; Gustavsen, Alice mfl.. 2023, Cell reports. TÜ, NTNU, UIO, OUSVitenskapelig artikkel

Rituximab-treated patients with lymphoma develop strong CD8 T-cell responses following COVID-19 vaccination.

Riise, Jon; Meyer, Saskia; Blaas, Isaac; Chopra, Adity; Tran, Trung; Delic-Sarac, Marina; Hestdalen, Malu Lian; Brodin, Ellen Elisabeth; Rustad, Even Holth; Dai, Ke-Zheng mfl.. 2022, British Journal of Haematology. SUS, STOLAV, UNN, HAUKELAND, UIO, AHUS, OUSVitenskapelig artikkel

1 - 3 av 3